Novo Nordisk
NVO
#91
Rank
โ‚น19.514 T
Marketcap
โ‚น4,407
Share price
1.41%
Change (1 day)
-26.70%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Earnings for Novo Nordisk (NVO)

Earnings in 2026 (TTM): โ‚น2.254 Trillion

According to Novo Nordisk's latest financial reports the company's current earnings are โ‚น51.37 Billion. In 2025 the company made an earning of โ‚น1.985 Trillion, an increase over its 2024 earnings that were of โ‚น1.868 Trillion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novo Nordisk from 1984 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) โ‚น2.254 T13.56%
2025 โ‚น1.985 T6.28%
2024 โ‚น1.868 T28.01%
2023 โ‚น1.459 T57.81%
2022 โ‚น924.80 B5.24%
2021 โ‚น878.79 B12.38%
2020 โ‚น781.97 B13.11%
2019 โ‚น691.34 B-3.45%
2018 โ‚น716.04 B1.88%
2017 โ‚น702.81 B4.3%
2016 โ‚น673.81 B10.32%
2015 โ‚น610.76 B7.47%
2014 โ‚น568.33 B3.4%
2013 โ‚น549.63 B19.09%
2012 โ‚น461.54 B15.58%
2011 โ‚น399.33 B16.58%
2010 โ‚น342.55 B25.66%
2009 โ‚น272.61 B10.68%
2008 โ‚น246.31 B55.82%
2007 โ‚น158.07 B7.02%
2006 โ‚น147.70 B19.05%
2005 โ‚น124.06 B10.55%
2004 โ‚น112.22 B
2002 โ‚น76.48 B-14.39%
2001 โ‚น89.33 B-52.82%
2000 โ‚น189.32 B250%
1999 โ‚น54.09 B31.21%
1998 โ‚น41.22 B34.31%
1997 โ‚น30.69 B11.46%
1996 โ‚น27.53 B9.03%
1995 โ‚น25.25 B-3.15%
1994 โ‚น26.07 B-0.67%
1993 โ‚น26.25 B45.38%
1992 โ‚น18.05 B-13.81%
1991 โ‚น20.95 B37.12%
1990 โ‚น15.27 B-0.79%
1989 โ‚น15.40 B26.2%
1988 โ‚น12.20 B24.97%
1987 โ‚น9.76 B-0.9%
1986 โ‚น9.85 B-7.78%
1985 โ‚น10.68 B24.87%
1984 โ‚น8.55 B

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
โ‚น1.003 T-57.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น2.948 T 24.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น725.44 B-69.38%๐Ÿ‡ซ๐Ÿ‡ท France
Bristol-Myers Squibb
BMY
โ‚น909.07 B-61.63%๐Ÿ‡บ๐Ÿ‡ธ USA